Zhejiang Tianyu Pharmaceutical Co Ltd (300702) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.063x

Based on the latest financial reports, Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a cash flow conversion efficiency ratio of 0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥233.18 Million ≈ $34.12 Million USD) by net assets (CN¥3.72 Billion ≈ $544.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Tianyu Pharmaceutical Co Ltd (300702) defensive interval to measure how many days the company can operate on defensive assets alone.

Zhejiang Tianyu Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Zhejiang Tianyu Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Tianyu Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Tianyu Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
ASA Gold and Precious Metals Ltd NYSE:ASA	-0.072x
Hunan Heshun Petroleum Co Ltd SHG:603353	0.129x
Suzhou Keda Technology Co Ltd SHG:603660	-0.011x
Jsti Group SHE:300284	-0.038x
Papa John's International Inc NASDAQ:PZZA	-0.017x
Rio2 Ltd TO:RIO	0.266x
Supalai Public Company Limited BK:SPALI-R	0.012x
Ayalon Holdings Ltd TA:AYAL	-0.012x

Annual Cash Flow Conversion Efficiency for Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Tianyu Pharmaceutical Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.50 Billion ≈ $511.83 Million	CN¥344.64 Million ≈ $50.43 Million	0.099x	+882.72%
2023-12-31	CN¥3.49 Billion ≈ $510.37 Million	CN¥-43.90 Million ≈ $-6.42 Million	-0.013x	+9.66%
2022-12-31	CN¥3.50 Billion ≈ $511.43 Million	CN¥-48.70 Million ≈ $-7.13 Million	-0.014x	+80.29%
2021-12-31	CN¥3.71 Billion ≈ $542.77 Million	CN¥-262.23 Million ≈ $-38.37 Million	-0.071x	-140.30%
2020-12-31	CN¥3.55 Billion ≈ $519.00 Million	CN¥622.18 Million ≈ $91.04 Million	0.175x	-16.47%
2019-12-31	CN¥2.04 Billion ≈ $298.10 Million	CN¥427.84 Million ≈ $62.61 Million	0.210x	+286.63%
2018-12-31	CN¥1.45 Billion ≈ $211.66 Million	CN¥78.57 Million ≈ $11.50 Million	0.054x	-20.98%
2017-12-31	CN¥1.29 Billion ≈ $188.43 Million	CN¥88.52 Million ≈ $12.95 Million	0.069x	-74.66%
2016-12-31	CN¥607.31 Million ≈ $88.87 Million	CN¥164.74 Million ≈ $24.11 Million	0.271x	+811.67%
2015-12-31	CN¥495.77 Million ≈ $72.55 Million	CN¥14.75 Million ≈ $2.16 Million	0.030x	-83.12%
2014-12-31	CN¥456.22 Million ≈ $66.76 Million	CN¥80.44 Million ≈ $11.77 Million	0.176x	+101.33%
2013-12-31	CN¥453.68 Million ≈ $66.39 Million	CN¥39.73 Million ≈ $5.81 Million	0.088x	--

About Zhejiang Tianyu Pharmaceutical Co Ltd

SHE:300702 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.03 Billion

CN¥7.00 Billion CNY

Market Cap Rank

#8974 Global

#2266 in China

Share Price

CN¥20.13

Change (1 day)

+3.82%

52-Week Range

CN¥18.09 - CN¥29.77

All Time High

CN¥69.67